What is ProteinQure?
ProteinQure operates at the intersection of biotechnology and precision medicine, focusing on the development of unique drug-like peptides through its ProteinStudio platform. This platform integrates molecular simulations and AI models to design peptides that are then validated through partnerships with leading pharmaceutical companies. The company's core mission is to transform patient care and treatment outcomes by enhancing drug delivery mechanisms and reducing adverse effects, positioning itself as a key player in the evolving landscape of therapeutic innovation.
How much funding has ProteinQure raised?
ProteinQure has raised a total of $15M across 2 funding rounds:
Angel/Seed
$4M
Series A
$11M
Angel/Seed (2019): $4M with participation from Golden Ventures, 8VC, iNovia, Global Founders Capital, Felicis Ventures, and Tom Williams
Series A (2025): $11M, investors not publicly disclosed
Key Investors in ProteinQure
Golden Ventures
Golden Ventures is a venture capital fund specializing in mobile-focused seed and early-stage investments, providing funding and mentorship to entrepreneurs in the mobile products and services sector.
8VC
8VC is a venture capital firm that invests in early-stage technology companies, focusing on disruptive innovations and supporting founders through their growth phases.
iNovia
iNovia Capital is a venture firm that partners with founders to build global technology companies, emphasizing a people-first investment strategy.
What's next for ProteinQure?
With the recent major strategic investment and a history of significant capital raises, ProteinQure is poised for accelerated growth and development. The company's focus on leveraging advanced computational tools and AI for peptide design suggests a strategic direction towards scaling its platform and expanding its therapeutic pipeline. Future endeavors will likely involve further validation of its peptide technologies, forging deeper partnerships within the pharmaceutical industry, and potentially advancing its lead candidates through clinical trials. This strategic financing will be instrumental in achieving these milestones and solidifying its market position in precision medicine.
See full ProteinQure company page
